Chief Executive Officer

Chief Financial Officer

Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases

Jade Biosciences Announces $135 Million Private Placement

Sr. Director, GMP Quality Assurance

Jade Biosciences is focused on developing innovative therapies for autoimmune diseases. The Sr. Director, GMP Quality Assurance will lead QA oversight for contract manufacturers and ensure compliance with cGMP regulations, collaborating closely with various teams to support product quality and strategy.

Sign up with Google

Sign in with Google